Clinical trials
Recruiting Breast Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University Hospital, Singapore | 5 |
| National Cancer Centre, Singapore | 3 |
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| KK Women's and Children's Hospital | 2 |
| Merck Sharp & Dohme LLC | 2 |
| ALX Oncology Inc. | 1 |
| BioNTech SE | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 28 |
| Triple Negative Breast Neoplasms | 5 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Brain Injuries, Traumatic | 1 |
| Breast Neoplasms, Male | 1 |
| Dermatitis | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.